SCHEMBL6351992

SCHEMBL6351992

N#Cc1ccc(NC(=O)c2ccc3c(c2)OCO3)c(C(=O)O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.61
RAB9A P51151 8/20 0.61
PTGS2 P35354 1/20 0.57
ALB P02768 1/20 0.55
PKM P14618 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
ALDH1A1 P00352 4/20 0.52
MAPT P10636 3/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
KMT2A Q03164 2/20 0.52
CASP3 P42574 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
MEN1 O00255 1/20 0.51
ABCC9 O60706 1/20 0.50
HPGD P15428 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MAPK1 P28482 2/20 0.49
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6359401 0.82 ALB (0.63) NPC1RAB9AALBPKMALDH1A1
SCHEMBL6349587 0.82 NPC1 (0.64) NPC1RAB9APTGS2PKMSMN1; SMN2
SCHEMBL6833729 0.80 NPC1 (0.61) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL6346687 0.80 ALB (0.60) RAB9AALBPKMALDH1A1MAPT
SCHEMBL6834460 0.79 POLB (0.44) NPC1RAB9AALBSMN1; SMN2MAPT
SCHEMBL6353963 0.79 KMT2A (0.62) ALBPKMALDH1A1MAPTKMT2A
SCHEMBL6348543 0.78 ALB (0.58) ALBPKMALDH1A1MAPTKMT2A
SCHEMBL19575765 0.77 KMT2A (0.54) NPC1RAB9AALBSMN1; SMN2ALDH1A1
SCHEMBL6352338 0.77 KMT2A (0.57) NPC1RAB9AALBPKMKMT2A
SCHEMBL6351469 0.77 AKR1C2 (0.66) RAB9AALBPKMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 NPC1 3512/4885RAB9A 3062/4885PTGS2 2569/4885
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 NPC1 3778/4885RAB9A 4337/4885PTGS2 1784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.